Over the past 12 months, 0 insiders at Zynerba Pharmaceuticals, Inc. filed 0 open-market SEC Form 4 transactions on ZYNE: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 13, 23 | Armando AnidoChairman & Chief Exec. Officer | SELL | 17.8K | $1.33 | $24K |
| Sep 13, 23 | James E FickenscherChief Financial Officer | SELL | 9.0K | $1.33 | $12K |
| Sep 13, 23 | Kenneth T JonesSee Remarks | SELL | 2.5K | $1.33 | $3K |
| Sep 13, 23 | Brian RosenbergerVP, Commercial & Business Dev. | SELL | 6.4K | $1.33 | $9K |
| Sep 13, 23 | Terri B SebreePresident | SELL | 12.4K | $1.33 | $16K |
| Jun 14, 23 | John P. ButlerDirector | SELL | 115 | $0.35 | $40 |
| Jun 14, 23 | Warren D CooperDirector | SELL | 115 | $0.35 | $40 |
| Jun 14, 23 | William J FedericiDirector | SELL | 115 | $0.35 | $40 |
| Jun 14, 23 | Daniel L KisnerDirector | SELL | 115 | $0.35 | $40 |
| Jun 14, 23 | Kenneth I MochDirector | SELL | 115 | $0.35 | $40 |
| Jun 14, 23 | Pamela StephensonDirector | SELL | 115 | $0.35 | $40 |
| Feb 15, 23 | Albert P ParkerChief Legal Officer | SELL | 3.2K | $0.54 | $2K |
| Jan 23, 23 | Armando AnidoChairman & Chief Exec. Officer | SELL | 35.5K | $0.60 | $21K |
| Jan 23, 23 | James E FickenscherChief Financial Officer | SELL | 17.8K | $0.60 | $11K |
| Jan 23, 23 | Brian RosenbergerVP, Commercial & Business Dev. | SELL | 12.7K | $0.60 | $8K |
| Jan 23, 23 | Terri B SebreePresident | SELL | 24.7K | $0.60 | $15K |
| Jul 19, 22 | Armando AnidoChairman & CEO | SELL | 11.9K | $1.10 | $13K |
| Jul 19, 22 | James E FickenscherChief Financial Officer | SELL | 6.0K | $1.10 | $7K |
| Jul 19, 22 | Brian RosenbergerVP, Commercial & Business Dev. | SELL | 4.3K | $1.10 | $5K |
| Jul 19, 22 | Terri B SebreePresident | SELL | 8.3K | $1.10 | $9K |
| Jun 14, 22 | John P. ButlerDirector | SELL | 53 | $1.01 | $54 |
| Jun 14, 22 | Warren D CooperDirector | SELL | 40 | $1.01 | $40 |
| Jun 14, 22 | William J FedericiDirector | SELL | 40 | $1.01 | $40 |
| Jun 14, 22 | Daniel L KisnerDirector | SELL | 40 | $1.01 | $40 |
| Jun 14, 22 | Kenneth I MochDirector | SELL | 40 | $1.01 | $40 |
| Jun 14, 22 | Pamela StephensonDirector | SELL | 40 | $1.01 | $40 |
Over the past 12 months, insiders at Zynerba Pharmaceuticals, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on ZYNE, which makes them mixed over the period. The most recent Form 4 was filed on .
0 different insiders at Zynerba Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on ZYNE over the last 12 months.
InsiderTape plots every ZYNE insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Zynerba Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →